Literature DB >> 29923125

Validation and application of a novel APC antibody in western blotting, immunoprecipitation, and immunohistochemistry.

Nami O Yamada1, Shuji Matsuda2, Takao Senda2.   

Abstract

Adenomatous polyposis coli (APC) is a large protein with multiple binding partners, suggesting diverse functions besides its well-known role in the destruction of β-catenin. To elucidate these complex functions, it is crucial to evaluate the precise subcellular distribution of APC within a cell and tissue. However, most of the commercially available anti-APC antibodies can only be used for limited applications, resulting in the use of independently generated antibodies. This has led to various discrepancies between studies as a common antibody has not been established. In this study, we generated an antibody against the c-terminal domain of human APC, designated APC-C antibody, and evaluated its specificity and application in various immunological methods. Our data indicate that this novel APC-C antibody is a specific and versatile antibody that can be used in western blotting, immunoprecipitation, immunocytochemistry, and immunohistochemistry. Widespread use of this APC antibody will help enhance our understanding of APC's function in both normal and cancer cell biology.

Entities:  

Keywords:  Adenomatous polyposis coli; Antibody; Immunocytochemistry; Immunohistochemistry; Immunoprecipitation

Mesh:

Substances:

Year:  2018        PMID: 29923125     DOI: 10.1007/s00795-018-0196-9

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  28 in total

1.  Some fine-structural findings on the thyroid gland in Apc1638T/1638T mice that express a C-terminus lacking truncated Apc.

Authors:  Atsushi Yokoyama; Ryuji Nomura; Masafumi Kurosumi; Atsushi Shimomura; Takanori Onouchi; Akiko Iizuka-Kogo; Ron Smits; Riccardo Fodde; Mditsuyasu Itoh; Takao Senda
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

2.  A disturbance of intestinal epithelial cell population and kinetics in APC1638T mice.

Authors:  Tuya Wang; Takanori Onouchi; Nami O Yamada; Shuji Matsuda; Takao Senda
Journal:  Med Mol Morphol       Date:  2017-01-09       Impact factor: 2.309

3.  Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein.

Authors:  K L Neufeld; R L White
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  Redefining the subcellular location and transport of APC: new insights using a panel of antibodies.

Authors:  Mariana Brocardo; Inke S Näthke; Beric R Henderson
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Novel association of APC with intermediate filaments identified using a new versatile APC antibody.

Authors:  Yang Wang; Yoshiaki Azuma; David B Friedman; Robert J Coffey; Kristi L Neufeld
Journal:  BMC Cell Biol       Date:  2009-10-21       Impact factor: 4.241

7.  Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation.

Authors:  A R Moser; A R Shoemaker; C S Connelly; L Clipson; K A Gould; C Luongo; W F Dove; P H Siggers; R L Gardner
Journal:  Dev Dyn       Date:  1995-08       Impact factor: 3.780

8.  The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration.

Authors:  I S Näthke; C L Adams; P Polakis; J H Sellin; W J Nelson
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

9.  Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli.

Authors:  G T Roberts; M L Davies; J A Wakeman
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

10.  Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia.

Authors:  Takanori Onouchi; Katsunori Kobayashi; Kazuyoshi Sakai; Atsushi Shimomura; Ron Smits; Chiho Sumi-Ichinose; Masafumi Kurosumi; Keizo Takao; Ryuji Nomura; Akiko Iizuka-Kogo; Hidenori Suzuki; Kazunao Kondo; Tetsu Akiyama; Tsuyoshi Miyakawa; Riccardo Fodde; Takao Senda
Journal:  Mol Brain       Date:  2014-03-29       Impact factor: 4.041

View more
  1 in total

1.  Decreased Podocyte Vesicle Transcytosis and Albuminuria in APC C-Terminal Deficiency Mice with Puromycin-Induced Nephrotic Syndrome.

Authors:  Saaya Hatakeyama; Akihiro Tojo; Hiroshi Satonaka; Nami O Yamada; Takao Senda; Toshihiko Ishimitsu
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.